ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADMA Adma Biologics Inc

6.51
-0.03 (-0.46%)
Pre Market
Last Updated: 21:31:38
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Adma Biologics Inc ADMA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.03 -0.46% 6.51 21:31:38
Open Price Low Price High Price Close Price Previous Close
6.54
more quote information »

Recent News

Date Time Source Heading
12/3/202407:05EDGAR2Form 8-K - Current report
12/3/202403:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/3/202422:00GLOBEADMA Biologics Announces FDA Approvals of Extended Room..
09/3/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:05EDGAR2Form 8-K - Current report
05/3/202423:00GLOBEADMA Biologics to Participate in the Raymond James..
05/3/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202408:21EDGAR2Form 8-K - Current report
29/2/202408:15EDGAR2Form 8-K - Current report
29/2/202408:10GLOBEADMA Biologics Announces CFO Transition
29/2/202408:05GLOBEADMA Biologics Announces Fourth Quarter and Full Year 2023..
28/2/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202408:05GLOBEADMA Biologics to Report Fourth Quarter and Full Year 2023..
22/2/202400:00EDGAR2Form 8-K - Current report
21/2/202423:00GLOBEADMA Biologics Successfully Implements Innovative AI..
15/2/202403:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/1/202400:00EDGAR2Form 8-K - Current report
08/1/202423:30EDGAR2Form 8-K - Current report
08/1/202423:00GLOBEADMA Biologics Announces Preliminary Fourth Quarter 2023..
06/1/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202308:05GLOBEADMA Biologics Announces $135 Million Non-Dilutive..
13/12/202308:30EDGAR2Form 8-K - Current report
12/12/202323:00GLOBEADMA Biologics Announces FDA Approval for BIVIGAMĀ® in the..
17/11/202308:31EDGAR2Form 8-K - Current report
16/11/202323:00GLOBEADMA BioCenters Receives FDA Approval for its Tenth Plasma..
09/11/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:36EDGAR2Form 8-K - Current report
09/11/202308:05GLOBEADMA Biologics Announces Third Quarter 2023 Financial..
01/11/202322:00GLOBEADMA Biologics to Report Third Quarter 2023 Financial..
04/10/202312:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/10/202307:45EDGAR2Form 8-K - Current report
31/8/202306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202309:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202310:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202307:09EDGAR2Form 144 - Report of proposed sale of securities
19/8/202311:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202302:58EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
18/8/202311:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202310:47EDGAR2Form 144 - Report of proposed sale of securities
10/8/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:15EDGAR2Form 8-K - Current report
10/8/202306:05GLOBEADMA Biologics Announces Second Quarter 2023 Financial..
02/8/202321:00GLOBEADMA Biologics to Report Second Quarter 2023 Financial..
19/7/202321:30EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock